Novartis, Merck & Allergan Join Those Raising U.S. Drug Prices for 2020
Phase 3 Results for Ixekizumab Promising in Patients with Non-Radiographic Axial Spondyloarthritis
EU Approves Remsima SC, a Biosimilar to Infliximab
FDA Approves Nintedanib for SSc-ILD, But Temper Your Expectations
Anifrolumab Promising for SLE
Pegloticase & Methotrexate Combination Therapy May Benefit Patients with Uncontrolled Gout
FDA Approves Amgen’s Infliximab Biosimilar Treatment
Tildrakizumab Promising for Psoriasis in Patients with PsA
How to Address Opioid Abuse with Patients
- 1
- 2
- 3
- …
- 98
- Next Page »